scispace - formally typeset
J

Jennie Ponsford

Researcher at Monash University, Clayton campus

Publications -  443
Citations -  21759

Jennie Ponsford is an academic researcher from Monash University, Clayton campus. The author has contributed to research in topics: Traumatic brain injury & Poison control. The author has an hindex of 73, co-authored 393 publications receiving 18379 citations. Previous affiliations of Jennie Ponsford include Monash University & Maastricht University.

Papers
More filters
Journal ArticleDOI

Predicting co-morbid traumatic brain injury and psychosis from neuropsychological profile.

TL;DR: This poster presents a poster presented at the 2016 Australian Neuroscience Conference exploring the role of emotion and language in the development of psychopathology and its role in disability.
Journal ArticleDOI

Brain age in chronic traumatic brain injury

TL;DR: In this paper , the authors investigated whether brain age increases with years post injury, and whether it is associated with injury severity, cognition and functional outcome, and found that greater brain age was associated with greater injury severity measured by post traumatic amnesia duration and Glasgow Coma Scale.
Journal ArticleDOI

"I've never been positive … I am now": Participant perspectives of a Positive Behaviour Support intervention (PBS + PLUS) for community-living individuals with ABI and their close others.

TL;DR: In this paper, the authors explored the perspectives of individuals with ABI and their close others (family members, friends, and carers) who had completed an individualized 12-month Positive Behaviour Support intervention.
Journal ArticleDOI

Interdisciplinary Rehabilitation for Concussion Recovery (i-RECOveR): protocol of an investigator-blinded, randomised, case series with multiple baseline design to evaluate the feasibility and preliminary efficacy of a 12-week treatment for persistent post-concussion symptoms

TL;DR: In this paper , the feasibility and preliminary efficacy of interdisciplinary concussion intervention and whether proceeding to a future definitive phase-2 randomised controlled trial is worthwhile were explored. But, the feasibility of this intervention was not explored.